An international randomized trial of candidate vaccines against COVID-19
Acronym:
STV
Timeline:
2022 – 2024
Status:
Completed
Site Principal Investigators:
Prof. Elizabeth Bukusi
Imeldah Wakhungu
Dr. Ken Abuka
Funder:
WHO, KAVI, UON
Objective
The major goal of this project is to evaluate the effect of novel vaccines on the rate of virologically confirmed COVID-19 disease, regardless of severity.